GlassScriptPhysician profile
Richard David Reitman
NPI 1811938129
$227,265.46
in general payments reported to CMS, 2019-2025
19 companies · $10K in 2025
The $10K reported for 2025 was more than what 77% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $93K · 2020: $90K · 2021: $117 · 2022: $4,518 · 2023: $13K · 2024: $16K · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $21K · Royalty Or License: $16K · Food and Beverage: $3,702.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $20,600.00 |
| Royalty Or License | $15,655.34 |
| Food and Beverage | $3,701.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, LP | $180,051.17 | 2019-2023 | Djo Surgical |
| Shalby Advanced Technologies, INC. | $33,321.16 | 2021-2025 | Tahoe Uni Knee System, Tracone Uni Knee System, Tahoe Uni Knee System |
| Kyocera Medical Technologies, INC. | $9,837.05 | 2019-2024 | |
| Omnilife Science, INC | $2,135.41 | 2020-2024 | Various Products |
| Corin USA | $500.00 | 2019 | |
| Stryker Corporation | $360.18 | 2019-2025 | Insignia, Prophecy, Inbone |
| Orthalign INC | $194.32 | 2019-2024 | Orthalign Plus |
| Microport Orthopedics INC | $140.16 | 2019 | |
| Zimmer Biomet Holdings, INC. | $140.05 | 2024-2025 | Avenir, Persona |
| Maxx Orthopedics, INC. | $104.27 | 2023 | |
| Arthrex, INC. | $101.89 | 2023 | Arthrex |
| Depuy Synthes Sales INC. | $89.44 | 2022-2025 | Na, Orthovisc, Monovisc |
| Ferring Pharmaceuticals INC. | $77.12 | 2020-2025 | Euflexxa |
| Tracpatch Health, INC | $70.95 | 2019 | |
| Bioventus LLC | $60.45 | 2024-2025 | Durolane |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $29.53 | 2025 | Bone Anchors With Arthroscopic Delivery System |
| Kerecis Limited | $19.90 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Davol INC. | $17.71 | 2025 | Arista |
| Vertex Pharmaceuticals Incorporated | $14.70 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Reitman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.